The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 3, 2014, Pages 247.e1-247.e7

  Zera, Chloe A ^a,b   Seely, Ellen W ^a,b   Wilkins Haug, Louise E ^a,b   Lim, Kee Hak ^b,c   Parry, Samuel I ^d   McElrath, Thomas F ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

angiogenic markers; obesity; placenta; preeclampsia; soluble fms like tyrosine kinase 1

Indexed keywords

FMS LIKE TYROSINE KINASE 1; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADULT; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL OBESITY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SECONDARY ANALYSIS; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY;

ANGIOGENIC MARKERS; OBESITY; PLACENTA; PREECLAMPSIA; SOLUBLE FMS-LIKE TYROSINE KINASE-1;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 85058205666     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.03.020     Document Type: Conference Paper

References (23)

1. S.Y. Chu, S.Y. Kim, and C.L. Bish Prepregnancy obesity prevalence in the United States, 2004-2005 Matern Child Health J 13 2009 614 620
2. M.I. Cedergren Maternal morbid obesity and the risk of adverse pregnancy outcome Obstet Gynecol 103 2004 219 224
3. J.L. Weiss, F.D. Malone, and D. Emig et al. Obesity, obstetric complications and cesarean delivery rate - a population-based screening study Am J Obstet Gynecol 190 2004 1091 1097
4. J. Gardosi, M. Williams, and A. Francis Stillbirth in pregnancies of obese mothers is associated with increased risk of fetal growth restriction Am J Obstet Gynecol 206 2009 S223
5. J. Gardosi, M. Williams, and A. Francis Clinical causes of stillbirth associated with maternal obesity Am J Obstet Gynecol 201 2009 S223
6. S.Y. Chu, S.Y. Kim, and J. Lau et al. Maternal obesity and risk of stillbirth: a metaanalysis Am J Obstet Gynecol 197 2007 223 228
7. S. Cnattingius, R. Bergstrom, L. Lipworth, and M.S. Kramer Prepregnancy weight and the risk of adverse pregnancy outcomes N Engl J Med 338 1998 147 152
8. J.R. Challis, C.J. Lockwood, L. Myatt, J.E. Norman, J.F. Strauss 3rd, and F. Petraglia Inflammation and pregnancy Reprod Sci 16 2009 206 215
9. P. Ziccardi, F. Nappo, and G. Giugliano et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year Circulation 105 2002 804 809
10. J.S. Yudkin, C.D. Stehouwer, J.J. Emeis, and S.W. Coppack C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 1999 972 978
11. S.E. Maynard, J.Y. Min, and J. Merchan et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
12. R.J. Levine, S.E. Maynard, and C. Qian et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
13. R. Adya, B.K. Tan, A. Punn, J. Chen, and H.S. Randeva Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/akt signalling pathways: novel insights into visfatin-induced angiogenesis Cardiovasc Res 78 2008 356 365
14. N. Suwaki, H. Masuyama, and H. Nakatsukasa et al. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia Am J Obstet Gynecol 195 2006 1687 1692
15. H. Masuyama, T. Segawa, and Y. Sumida et al. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia BJOG 117 2010 314 320
16. T.F. McElrath, K.H. Lim, and E. Pare et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy Am J Obstet Gynecol 207 2012 407.e1 407.e7
17. T.F. McElrath, J.L. Hecht, and O. Dammann et al. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification Am J Epidemiol 168 2008 980 989
18. ACOG Committee on Practice Bulletins - Obstetrics Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin number 33 Obstet Gynecol 99 2002 159 167
19. G.C. Smith, J.A. Crossley, and D.A. Aitken et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth Obstet Gynecol 109 2007 1316 1324
20. J.M. Faupel-Badger, A.C. Staff, and R. Thadhani et al. Maternal angiogenic profile in pregnancies that remain normotensive Eur J Obstet Gynecol Reprod Biol 158 2011 189 193
21. L.K. Callaway, M. O'Callaghan, and H.D. McIntyre Obesity and the hypertensive disorders of pregnancy Hypertens Pregnancy 28 2009 473 493
22. V.H. Roberts, J. Smith, S.A. McLea, A.B. Heizer, J.L. Richardson, and L. Myatt Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta Placenta 30 2009 169 175
23. D. Sundrani, V. Khot, and H. Pisal et al. Gestation dependent changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy PLoS One 8 2013 e54153